Ramco Systems surges 7% after winning HAECO ITM contract
Global enterprise software provider Ramco Systems has secured an
order for Ramco Aviation Suite from Hong Kong Aircraft Engineering Company
(HAECO), which is among the world’s leading independent aircraft engineering
and maintenance, repair, and overhaul groups.
Ramco will provide end-to-end solutions to HAECO ITM, a HAECO
Group company which provides inventory technical management solutions. It does
this by unifying various techno-commercial functions such as covering customer
contract management, supply chain management, inventory management, financial
management, and component engineering including reliability management.
Shalimar Paints surges ~7% after board approves rights issue
Mumbai-headquartered Shalimar Paints surged ~7% after its board
approved a proposed rights issue worth up to Rs240cr. Further, the board has
also given its assent to re-establishing the company’s Nashik plant and for
setting up of a new regional distribution center there.
This meeting of the board of directors was held on Tuesday, July
10.
Lupin to co-market two of Boehringer Ingelheim’s novel
anti-diabetes drugs in India
Lupin has extended its partnership with German-based pharma major
Boehringer Ingelheim. Through this extension, Lupin is planning to market two
new oral anti-diabetics recently approved in India -- Gibtulio Met
(Empagliflozin + Metformin) and Ajaduo (Empagliflozin + Linagliptin).
Both products will be launched for the first time in India and
will be simultaneously co-marketed under different brand names by Boehringer
and Lupin across India.
Aurobindo Pharma receives USFDA approval for Azithromycin
tablets
Aurobindo Pharma has received final USFDA approval to manufacture
Azithromycin tablets 250 mg and 500 mg.
Aurobindo’s Azithromycin is the generic equivalent of Pfizer's
Zithromax tablets. Azithromycin is indicated for the treatment of patients with
mild to moderate infections.
Glenmark launches Helsinn's Akynzeo in India
Glenmark Pharma has exclusively launched Akynzeo, a fixed dose
combination drug (netupitant 300mg/palonosetron 0.5mg). Akynzeo is a
single-dose oral capsule for each chemotherapy cycle that covers both the acute
and delayed phase of chemotherapy-induced nausea and vomiting.
The drug has been developed by Swiss company Helsinn and Glenmark
has exclusive marketing rights of this drug in India and Nepal.
Financial Advisory Company in Indore, Stock Advisory Company in Indore , Equity Tips Free Trading Tips , MCX Tips , sebi registered advisory company , Intraday stock tips , Capitalstars Video Gallery
CapitalStars Provides Free Trial To Our Client
0 comments:
Post a Comment